Exchange: NYSEMkt·Updated 02:39 PM EDT

NSRX Nasus Pharma Ltd.

$4.10
$0.05
(1.24%)
Today
Mkt Cap$47.43M
Vol5,552.00

About NSRX

Nasus Pharma Ltd. engages in the development of intranasal drugs for emergency medical conditions. It offers Powder-Based Intranasal (PBI) specialized product portfolio, to address acute medical conditions and public health threats. The company was founded by Udi Gilboa and Dalia Megiddo in May 2019 and is headquartered in Tel Aviv, Israel.
47

Neutral Sentiment

How do you feel about NSRX?

Advertisement|Remove ads.